SCHEMBL5658689

SCHEMBL5658689

Cn1cccc1C(=O)N1CCN(c2ccccc2)CC1

nearest known ligand 0.78

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP2 O75604 9/20 0.78
CYP1A2 P05177 8/20 0.78
CYP3A4 P08684 6/20 0.78
KMT2A Q03164 5/20 0.78
MEN1 O00255 4/20 0.78
HPGD P15428 3/20 0.78
HIF1A Q16665 3/20 0.78
TP53 P04637 2/20 0.78
ALDH1A1 P00352 7/20 0.67
TSHR P16473 6/20 0.67
SMN1; SMN2 Q16637 5/20 0.67
CYP2C19 P33261 4/20 0.67
CYP2C9 P11712 4/20 0.67
GAA P10253 1/20 0.67
MAPK1 P28482 4/20 0.62
HSD17B10 Q99714 2/20 0.62
CYP2D6 P10635 1/20 0.61
HPGDS O60760 2/20 0.59
ALOX15 P16050 1/20 0.58
APOBEC3A P31941 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30125105 0.85 CYP1A2 (0.58) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL30124750 0.85 CYP1A2 (0.58) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL30124856 0.84 USP2 (0.59) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL5655889 0.82 KMT2A (0.63) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL14590544 0.81 KMT2A (0.57) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL5655224 0.80 ALDH1A1 (0.69) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL3763788 0.79 MAOB (0.64) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL23928581 0.78 GAA (0.58) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL23000070 0.78 HPGDS (0.81) USP2CYP1A2CYP3A4KMT2AMEN1
SCHEMBL23928553 0.77 GAA (0.57) USP2CYP1A2CYP3A4KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7229991-B2 Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides GRUENENTHAL GMBH (DE) 2007-06-12 US disclosed
US-20050288342-A1 Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides GRUENENTHAL GMBH (DE) 2005-12-29 US disclosed
EP-1581490-A1 SUBSTITUTED 5-AMINOMETHYL-1H-PYRROLE-2-CARBOXAMIDES Grünenthal GmbH (DE) 2005-10-05 EP disclosed
WO-2004058707-A1 SUBSTITUTED 5-AMINOMETHYL-1H-PYRROLE-2-CARBOXAMIDES Grünenthal GmbH (DE) 2004-07-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050288342-A1 Substituted 5-aminomethyl-1H-pyrrole-2-carboxamides QPCT, PGA5, ALDH18A1 USP2 3015/4885CYP1A2 129/4885CYP3A4 310/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.